vimarsana.com
Home
Live Updates
Labcorp Strengthens Oncology Leadership Position with the Ad
Labcorp Strengthens Oncology Leadership Position with the Ad
Labcorp Strengthens Oncology Leadership Position with the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
BURLINGTON, N.C., Dec. 23, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc.
Related Keywords
Kilpatrick Townsend ,
Adam Schechter ,
Hogan Lovells ,
Megan Bailey ,
Genome Diagnostics Inc ,
Drug Administration ,
Broader Access ,
Innovative Diagnostics Improves Patient Outcomes ,
Accelerates Clinical ,
Personal Genome Diagnostics ,
Hart Scott Rodino Antitrust Improvements Act ,
Cancer ,
Ceo ,
Financial Services ,
Genomics ,
Information Technology ,
Johns Hopkins University ,
Medicine ,
Merger And Acquisition ,
Pharmaceuticals ,
Twitter ,
Biopsy ,
Branches Of Biology ,
Burlington ,
North Carolina ,
Clinical Medicine ,
Labcorp ,
Labcorp Drug Development ,
Liquid Biopsy ,
Precision Medicine ,